| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Imaging, Diagnosis, Prognosis |
Authors' Affiliations: 1 Department of Molecular and Surgical Oncology, Medical Institute of Bioregulation, Kyushu University, Beppu and 2 Department of Radiology, University of the Ryukyus, Okinawa, Japan
Requests for reprints: Masaki Mori, Department of Molecular and Surgical Oncology, Medical Institute of Bioregulation, Kyushu University, Tsurumihara 4546, Beppu 874-0838, Japan. Phone: 81-977-27-1650; Fax: 81-977-27-1651; E-mail: mmori{at}tsurumi.beppu.kyushu-u.ac.jp.
Purpose: Human kallikrein gene 6 (KLK6) is a member of the human kallikrein gene family, and recent studies have found that many kallikreins have altered expression patterns in various malignancies. The purpose of the current study was to quantify the expression of KLK6 in malignant and benign colorectal tissues and to statistically analyze whether KLK6 expression levels correlate with clinicopathologic variables and prognosis in patients with colorectal cancer.
Experimental Designs: Paired colorectal tissue samples from cancerous and corresponding noncancerous tissues were obtained from 63 patients with colorectal cancer who underwent surgical resection. Quantitative analyses of KLK6 mRNA expression were done using real-time quantitative reverse transcription-PCR.
Results: KLK6 mRNA overexpression in cancerous tissues compared with normal counterparts was observed in 57 of 63 (90%) patients. The mean expression level of KLK6 mRNA in cancerous tissues was significantly higher than that in noncancerous tissues (P < 0.0001). Elevated KLK6 expression was significantly correlated with serosal invasion (P < 0.05), liver metastasis (P < 0.05), and advanced Duke's stage (P < 0.01). Furthermore, patients with high KLK6 expression had a significantly poorer actuarial overall survival than patients with low KLK6 expression (5-year overall survival rates: 54% and 73%, respectively, P < 0.05).
Conclusions: The results of this study indicated that KLK6 mRNA expression was significantly higher in cancerous than in noncancerous colorectal tissues, and high expression of KLK6 mRNA correlated with serosal invasion, liver metastasis, advanced Duke's stage, and a poor prognosis for patients with colorectal cancer.
Key Words: colorectal neoplasms • kallikrein 6 • KLK6 • quantitative real-time PCR • prognostic factors
This article has been cited by other articles:
|
|
 |
|
  T. Yokobori, K. Mimori, M. Iwatsuki, H. Ishii, I. Onoyama, T. Fukagawa, H. Kuwano, K. I. Nakayama, and M. Mori p53-Altered FBXW7 Expression Determines Poor Prognosis in Gastric Cancer Cases Cancer Res., May 1, 2009; 69(9): 3788 - 3794. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Sakashita, K. Mimori, F. Tanaka, Y. Kamohara, H. Inoue, T. Sawada, K. Hirakawa, and M. Mori Prognostic Relevance of Tensin4 Expression in Human Gastric Cancer Ann. Surg. Oncol., September 1, 2008; 15(9): 2606 - 2613. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Sakashita, K. Mimori, F. Tanaka, Y. Kamohara, H. Inoue, T. Sawada, K. Hirakawa, and M. Mori Clinical Significance of Loss of Fhl1 Expression in Human Gastric Cancer Ann. Surg. Oncol., August 1, 2008; 15(8): 2293 - 2300. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Yokoe, F. Tanaka, K. Mimori, H. Inoue, T. Ohmachi, M. Kusunoki, and M. Mori Efficient Identification of a Novel Cancer/Testis Antigen for Immunotherapy Using Three-Step Microarray Analysis Cancer Res., February 15, 2008; 68(4): 1074 - 1082. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Ieta, F. Tanaka, N. Haraguchi, Y. Kita, H. Sakashita, K. Mimori, T. Matsumoto, H. Inoue, H. Kuwano, and M. Mori Biological and Genetic Characteristics of Tumor-Initiating Cells in Colon Cancer Ann. Surg. Oncol., February 1, 2008; 15(2): 638 - 648. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Klucky, R. Mueller, I. Vogt, S. Teurich, B. Hartenstein, K. Breuhahn, C. Flechtenmacher, P. Angel, and J. Hess Kallikrein 6 Induces E-Cadherin Shedding and Promotes Cell Proliferation, Migration, and Invasion Cancer Res., September 1, 2007; 67(17): 8198 - 8206. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Nakamura, F. Tanaka, H. Nagahara, K. Ieta, N. Haraguchi, K. Mimori, A. Sasaki, H. Inoue, K. Yanaga, and M. Mori Opa Interacting Protein 5 (OIP5) Is a Novel Cancer-testis Specific Gene in Gastric Cancer Ann. Surg. Oncol., February 1, 2007; 14(2): 885 - 892. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Ohmachi, H. Inoue, K. Mimori, F. Tanaka, A. Sasaki, T. Kanda, H. Fujii, K. Yanaga, and M. Mori Fatty Acid Binding Protein 6 Is Overexpressed in Colorectal Cancer Clin. Cancer Res., September 1, 2006; 12(17): 5090 - 5095. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Ohmachi, F. Tanaka, K. Mimori, H. Inoue, K. Yanaga, and M. Mori Clinical Significance of TROP2 Expression in Colorectal Cancer. Clin. Cancer Res., May 15, 2006; 12(10): 3057 - 3063. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
